Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers
June 30, 2025
Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers
Science Magazine: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
June 30, 2025
Science Magazine: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
Medical Xpress: Urine-based tumor DNA test may help personalize bladder cancer treatment
June 30, 2025
Medical Xpress: Urine-based tumor DNA test may help personalize bladder cancer treatment
MSN.com: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
June 30, 2025
MSN.com: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
Bioengineer.org: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
June 30, 2025
Bioengineer.org: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
News-Medical: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
June 30, 2025
News-Medical: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy